The 3.2 million-square-foot distribution center for Amazon would rise nearly five stories at the site, if the plans are approved.

Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.

Gov. Hohcul announced part of Saint Rose campus will be turned into a workforce development hub as part of the ON RAMP initiative ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Regeneron's CD20xCD3 bispecific antibody for ... and 163,000 cases of DLBCL. "Building upon this approval, we are excited about our OLYMPIA program, which includes multiple phase 3 trials ...

Louisiana has lost 2,000 square miles of coastal wetlands since the 1930s. A Baton Rouge Magnet High student is studying the ...

BASIS Independent Schools is scheduled to open its third private institution in the Bay Area for grades sixth through 12th by ...

Some companies have announced diversity rollbacks — but many more are deleting or softening language from their investor disclosures, an NPR analysis finds.

BIOPHARMACEUTICAL firm Regeneron is to formally seek planning ... She also welcomed the building jobs, saying 250 is “a massive number of people”. “The construction industry has a long ...

Regeneron Pharmaceuticals announced positive three-year results from an extension study of EYLEA HD (aflibercept) Injection 8 mg for treating wet age-related macular degeneration (wAMD). The ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...

Pushkal Garg; Chief Medical Officer, Executive Vice President - Development and Medical Affairs; Alnylam Pharmaceuticals Inc Jeffrey Poulton; Chief Financial Officer, Executive Vice President; Alnylam ...